{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:16:03Z","timestamp":1789830963627,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Metabolic dysfunction-associated steatohepatitis (MASH) has become a major global health issue. Mitochondrial damage plays a crucial role in the development and progression of MASH. Therefore, it is speculated that mitochondrial transplantation therapy, which could replace dysfunctional mitochondria with normal ones, might potentially restore the liver cell metabolism of MASH. In palmitate-damaged AML-12 hepatocytes, exogenous mitochondria could eliminate lipid deposits and recover cell viability. However, in transforming growth factor \u03b2 (TGF-\u03b2)-activated hepatic stellate cells (HSCs), the exogenous mitochondria showed the capability to inhibit the generation of \u03b1-smooth muscle actin (\u03b1-SMA) and collagen I. Moreover, the mechanism by which the exogenous mitochondria initiated the mitochondria-nucleus signaling pathway of liver cells was studied. The results showed the mitochondria could prevent metabolism disorders in the liver cells by regulating silent information regulator 1 (SIRT1) activity. Subsequently, a MASH animal model was established by the administration of a high-fat diet and the intraperitoneal injection of carbon tetrachloride to Kunming mice. The results indicated that the mitochondrial therapy significantly inhibited the livery injury and restored liver cell function in the experimental MASH mice (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). The mitochondrial therapy would be a promising strategy to improve MASH pathological features, which could be developed as a new treatment option against MASH.<\/jats:p>","DOI":"10.1186\/s43556-025-00328-w","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:55:58Z","timestamp":1760172958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Healthy mitochondria attenuate metabolic dysfunction-associated steatohepatitis by restoring cell metabolism"],"prefix":"10.1186","volume":"6","author":[{"given":"Peiyu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,11]]},"reference":[{"issue":"2","key":"328_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189086","volume":"1879","author":"YD Sun","year":"2024","unstructured":"Sun YD, Zhang H, Li YM, Han JJ. Abnormal metabolism in hepatic stellate cells: Pandora\u2019s box of MAFLD related hepatocellular carcinoma. Biochim Biophys Acta Rev Cancer. 2024;1879(2):189086. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189086.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"328_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41586-023-06991-9","volume":"626","author":"W Fan","year":"2024","unstructured":"Fan W, Adebowale K, V\u00e1ncza L, Li Y, Rabbi MF, Kunimoto K, et al. Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver. Nature. 2024;626:635\u201342. https:\/\/doi.org\/10.1038\/s41586-023-06991-9.","journal-title":"Nature"},{"issue":"7","key":"328_CR3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","volume":"158","author":"RF Schwabe","year":"2020","unstructured":"Schwabe RF, Tabas I, Pajvani UB. Mechanisms of fibrosis development in nonalcoholic steatohepatitis. Gastroenterology. 2020;158(7):1913\u201328. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.311.","journal-title":"Gastroenterology"},{"key":"328_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105739","volume":"170","author":"N Bourebaba","year":"2021","unstructured":"Bourebaba N, Marycz K. Hepatic stellate cells role in the course of metabolic disorders development - a molecular overview. Pharmacol Res. 2021;170:105739. https:\/\/doi.org\/10.1016\/j.phrs.2021.105739.","journal-title":"Pharmacol Res"},{"issue":"3","key":"328_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.101115","volume":"11","author":"P Chen","year":"2023","unstructured":"Chen P, Yao L, Yuan M, Wang Z, Zhang Q, Jiang Y, et al. Mitochondrial dysfunction: a promising therapeutic target for liver diseases. Genes Dis. 2023;11(3):101115. https:\/\/doi.org\/10.1016\/j.gendis.2023.101115.","journal-title":"Genes Dis"},{"issue":"12","key":"328_CR6","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1016\/j.cell.2024.05.009","volume":"187","author":"S Sookoian","year":"2024","unstructured":"Sookoian S, Pirola CJ. Resmetirom for treatment of MASH. Cell. 2024;187(12):2897-2897.e1. https:\/\/doi.org\/10.1016\/j.cell.2024.05.009.","journal-title":"Cell"},{"key":"328_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101730","volume":"73","author":"L Chen","year":"2023","unstructured":"Chen L, Wang Y. Interdisciplinary advances reshape the delivery tools for effective NASH treatment. Mol Metab. 2023;73:101730. https:\/\/doi.org\/10.1016\/j.molmet.2023.101730.","journal-title":"Mol Metab"},{"issue":"1","key":"328_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cell.2020.08.009","volume":"183","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Liu J, Deng H, Ma R, Liao JY, Liang H, et al. Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output. Cell. 2020;183(1):76-93.e22. https:\/\/doi.org\/10.1016\/j.cell.2020.08.009.","journal-title":"Cell"},{"key":"328_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.02.033","author":"GR Steinberg","year":"2025","unstructured":"Steinberg GR, Valvano CM, De Nardo W, Watt MJ. Integrative metabolism in MASLD and MASH: pathophysiology and emerging mechanisms. J Hepatol. 2025. https:\/\/doi.org\/10.1016\/j.jhep.2025.02.033.","journal-title":"J Hepatol"},{"issue":"2","key":"328_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","volume":"33","author":"P Trivedi","year":"2021","unstructured":"Trivedi P, Wang S, Friedman SL. The power of plasticity-metabolic regulation of hepatic stellate cells. Cell Metab. 2021;33(2):242\u201357. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.026.","journal-title":"Cell Metab"},{"issue":"11","key":"328_CR11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.molmed.2023.08.001","volume":"29","author":"Z Che","year":"2023","unstructured":"Che Z, Zhou Z, Li SQ, Gao L, Xiao J, Wong NK. ROS\/RNS as molecular signatures of chronic liver diseases. Trends Mol Med. 2023;29(11):951\u201367. https:\/\/doi.org\/10.1016\/j.molmed.2023.08.001.","journal-title":"Trends Mol Med"},{"issue":"2","key":"328_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/hep.29514","volume":"67","author":"R Loomba","year":"2018","unstructured":"Loomba R, Lawitz E, Mantry PS, Jayakumar S, Caldwell SH, Arnold H, et al. The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: a randomized, phase 2 trial. Hepatology. 2018;67(2):549\u201359. https:\/\/doi.org\/10.1002\/hep.29514.","journal-title":"Hepatology"},{"issue":"9","key":"328_CR13","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.dld.2024.04.021","volume":"56","author":"ML Petroni","year":"2024","unstructured":"Petroni ML, Perazza F, Marchesini G. Breakthrough in the treatment of metabolic associated steatotic liver disease: is it all over? Dig Liver Dis. 2024;56(9):1442\u201351. https:\/\/doi.org\/10.1016\/j.dld.2024.04.021.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"328_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/biology12040595","volume":"12","author":"R Amorim","year":"2023","unstructured":"Amorim R, Magalh\u00e3es CC, Borges F, Oliveira PJ, Teixeira J. From non-alcoholic fatty liver to hepatocellular carcinoma: a story of (Mal)adapted mitochondria. Biology. 2023;12(4):595. https:\/\/doi.org\/10.3390\/biology12040595.","journal-title":"Biology"},{"issue":"3","key":"328_CR15","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.apsb.2022.10.008","volume":"13","author":"TG Zhang","year":"2023","unstructured":"Zhang TG, Miao CY. Mitochondrial transplantation as a promising therapy for mitochondrial diseases. Acta Pharm Sin B. 2023;13(3):1028\u201335. https:\/\/doi.org\/10.1016\/j.apsb.2022.10.008.","journal-title":"Acta Pharm Sin B"},{"issue":"9","key":"328_CR16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41565-024-01681-7","volume":"19","author":"Z Wu","year":"2024","unstructured":"Wu Z, Chen L, Guo W, Wang J, Ni H, Liu J, et al. Oral mitochondrial transplantation using nanomotors to treat ischaemic heart disease. Nat Nanotechnol. 2024;19(9):1375\u201385. https:\/\/doi.org\/10.1038\/s41565-024-01681-7.","journal-title":"Nat Nanotechnol"},{"issue":"10","key":"328_CR17","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1038\/s42255-024-01125-5","volume":"6","author":"R Nakai","year":"2024","unstructured":"Nakai R, Varnum S, Field RL, Shi H, Giwa R, Jia W, et al. Mitochondria transfer-based therapies reduce the morbidity and mortality of Leigh syndrome. Nat Metab. 2024;6(10):1886\u201396. https:\/\/doi.org\/10.1038\/s42255-024-01125-5.","journal-title":"Nat Metab"},{"issue":"5","key":"328_CR18","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.2174\/1570159X05666220908100545","volume":"21","author":"MM Khan","year":"2023","unstructured":"Khan MM, Paez HG, Pitzer CR, Alway SE. The therapeutic potential of mitochondria transplantation therapy in neurodegenerative and neurovascular disorders. Curr Neuropharmacol. 2023;21(5):1100\u201316. https:\/\/doi.org\/10.2174\/1570159X05666220908100545.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"328_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s42255-024-01200-x","volume":"7","author":"JR Brestoff","year":"2025","unstructured":"Brestoff JR, Singh KK, Aquilano K, Becker LB, Berridge MV, Boilard E, et al. Recommendations for mitochondria transfer and transplantation nomenclature and characterization. Nat Metab. 2025;7(1):53\u201367. https:\/\/doi.org\/10.1038\/s42255-024-01200-x.","journal-title":"Nat Metab"},{"key":"328_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-023-06537-z","volume":"623","author":"N Borcherding","year":"2023","unstructured":"Borcherding N, Brestoff JR. The power and potential of mitochondria transfer. Nature. 2023;623:283\u201391. https:\/\/doi.org\/10.1038\/s41586-023-06537-z.","journal-title":"Nature"},{"issue":"1","key":"328_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y Zong","year":"2024","unstructured":"Zong Y, Li H, Liao P, Chen L, Pan Y, Zheng Y, et al. Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):124. https:\/\/doi.org\/10.1038\/s41392-024-01839-8.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"328_CR22","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3390\/antiox12112006","volume":"12","author":"X Yang","year":"2023","unstructured":"Yang X, Zhou P, Zhao Z, Li J, Fan Z, Li X, et al. Improvement effect of mitotherapy on the cognitive ability of Alzheimer\u2019s disease through NAD+\/SIRT1-mediated autophagy. Antioxidants. 2023;12(11):2006. https:\/\/doi.org\/10.3390\/antiox12112006.","journal-title":"Antioxidants"},{"issue":"12","key":"328_CR23","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.7150\/thno.33100","volume":"9","author":"C Sun","year":"2019","unstructured":"Sun C, Liu X, Wang B, Wang Z, Liu Y, Di C, et al. Endocytosis-mediated mitochondrial transplantation: transferring normal human astrocytic mitochondria into glioma cells rescues aerobic respiration and enhances radiosensitivity. Theranostics. 2019;9(12):3595\u2013607. https:\/\/doi.org\/10.7150\/thno.33100.","journal-title":"Theranostics"},{"key":"328_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fphar.2017.00241","volume":"8","author":"A Fu","year":"2017","unstructured":"Fu A, Shi X, Zhang H, Fu B. Mitotherapy for fatty liver by intravenous administration of exogenous mitochondria in male mice. Front Pharmacol. 2017;8:241. https:\/\/doi.org\/10.3389\/fphar.2017.00241.","journal-title":"Front Pharmacol"},{"issue":"1","key":"328_CR25","doi-asserted-by":"publisher","first-page":"17450","DOI":"10.1038\/s41598-017-17813-0","volume":"7","author":"DB Cowan","year":"2017","unstructured":"Cowan DB, Yao R, Thedsanamoorthy JK, Zurakowski D, Del Nido PJ, McCully JD. Transit and integration of extracellular mitochondria in human heart cells. Sci Rep. 2017;7(1):17450. https:\/\/doi.org\/10.1038\/s41598-017-17813-0.","journal-title":"Sci Rep"},{"key":"328_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102026","volume":"45","author":"PA Kakimoto","year":"2021","unstructured":"Kakimoto PA, Serna JDC, de Miranda Ramos V, Zorzano A, Kowaltowski AJ. Increased glycolysis is an early consequence of palmitate lipotoxicity mediated by redox signaling. Redox Biol. 2021;45:102026. https:\/\/doi.org\/10.1016\/j.redox.2021.102026.","journal-title":"Redox Biol"},{"key":"328_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12964-024-01666-y","volume":"22","author":"M Peyman","year":"2024","unstructured":"Peyman M, Babin-Ebell A, Rodr\u00edguez-Rodr\u00edguez R, Rigon M, Aguilar-Recarte D, Villarroya J, et al. SIRT1 regulates hepatic vldlr levels. Cell Commun Signal. 2024;22:297. https:\/\/doi.org\/10.1186\/s12964-024-01666-y.","journal-title":"Cell Commun Signal"},{"key":"328_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116917","volume":"177","author":"L Yang","year":"2024","unstructured":"Yang L, Liu D, Jiang S, Li H, Chen L, Wu Y, et al. SIRT1 signaling pathways in sarcopenia: novel mechanisms and potential therapeutic targets. Biomed Pharmacother. 2024;177:116917. https:\/\/doi.org\/10.1016\/j.biopha.2024.116917.","journal-title":"Biomed Pharmacother"},{"key":"328_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176737","volume":"977","author":"D Meng","year":"2024","unstructured":"Meng D, Yin G, Chen S, Zhang X, Yu W, Wang L, et al. Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic SIRT1\/PGC-1\u03b1 pathway. Eur J Pharmacol. 2024;977:176737. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176737.","journal-title":"Eur J Pharmacol"},{"key":"328_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goae066","volume":"12","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Qiu T, Wang T, Yu B, Xia K, Guo J, et al. Research progress on the role of mitochondria in the process of hepatic ischemia-reperfusion injury. Gastroenterol Rep. 2024;12:goae066. https:\/\/doi.org\/10.1093\/gastro\/goae066.","journal-title":"Gastroenterol Rep"},{"key":"328_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13578-022-00805-7","volume":"12","author":"Z Liu","year":"2022","unstructured":"Liu Z, Sun Y, Qi Z, Cao L, Ding S. Mitochondrial transfer\/transplantation: an emerging therapeutic approach for multiple diseases. Cell Biosci. 2022;12:66. https:\/\/doi.org\/10.1186\/s13578-022-00805-7.","journal-title":"Cell Biosci"},{"key":"328_CR32","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41586-024-07340-0","volume":"629","author":"RZ Lin","year":"2024","unstructured":"Lin RZ, Im GB, Luo AC, Zhu Y, Hong X, Neumeyer J, et al. Mitochondrial transfer mediates endothelial cell engraftment through mitophagy. Nature. 2024;629:660\u20138. https:\/\/doi.org\/10.1038\/s41586-024-07340-0.","journal-title":"Nature"},{"key":"328_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mito.2022.04.004","volume":"65","author":"W Zhou","year":"2022","unstructured":"Zhou W, Zhao Z, Yu Z, Fu A. Mitochondrial transplantation therapy inhibits the proliferation of malignant hepatocellular carcinoma and its mechanism. Mitochondrion. 2022;65:11\u201322. https:\/\/doi.org\/10.1016\/j.mito.2022.04.004.","journal-title":"Mitochondrion"},{"issue":"1","key":"328_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s43556-024-00229-4","volume":"5","author":"Y Hu","year":"2024","unstructured":"Hu Y, Liu W, Fang W, Dong Y, Zhang H, Luo Q. Tumor energy metabolism: implications for therapeutic targets. Mol Biomed. 2024;5(1):63. https:\/\/doi.org\/10.1186\/s43556-024-00229-4.","journal-title":"Mol Biomed"},{"key":"328_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41586-023-06857-0","volume":"625","author":"C Moschandrea","year":"2024","unstructured":"Moschandrea C, Kondylis V, Evangelakos I, Herholz M, Schneider F, Schmidt C, et al. Mitochondrial dysfunction abrogates dietary lipid processing in enterocytes. Nature. 2024;625:385\u201392. https:\/\/doi.org\/10.1038\/s41586-023-06857-0.","journal-title":"Nature"},{"key":"328_CR36","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202304075","volume":"223","author":"J Ovciarikova","year":"2024","unstructured":"Ovciarikova J, Shikha S, Lacombe A, Courjol F, McCrone R, Hussain W, et al. Two ancient membrane pores mediate mitochondrial-nucleus membrane contact sites. J Cell Biol. 2024;223:e202304075. https:\/\/doi.org\/10.1083\/jcb.202304075.","journal-title":"J Cell Biol"},{"issue":"12","key":"328_CR37","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1016\/j.bbadis.2017.09.008","volume":"1863","author":"M Li","year":"2017","unstructured":"Li M, Hong W, Hao C, Li L, Xu H, Li P, et al. Hepatic stellate cell-specific deletion of SIRT1 exacerbates liver fibrosis in mice. Biochimica et Biophysica Acta (BBA). 2017;1863(12):3202\u201311. https:\/\/doi.org\/10.1016\/j.bbadis.2017.09.008.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"1","key":"328_CR38","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1096\/fj.201700612r","volume":"32","author":"M Li","year":"2018","unstructured":"Li M, Hong W, Hao C, Li L, Wu D, Shen A, et al. Sirt1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice. FASEB J. 2018;32(1):500\u201311. https:\/\/doi.org\/10.1096\/fj.201700612r.","journal-title":"FASEB J"},{"issue":"2","key":"328_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jhep.2024.08.009","volume":"82","author":"YJ Liu","year":"2025","unstructured":"Liu YJ, Kimura M, Li X, Sulc J, Wang Q, Rodr\u00edguez-L\u00f3pez S, et al. ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD\/MASH. J Hepatol. 2025;82(2):174\u201388. https:\/\/doi.org\/10.1016\/j.jhep.2024.08.009.","journal-title":"J Hepatol"},{"issue":"5","key":"328_CR40","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1113\/JP280908","volume":"600","author":"M Dall","year":"2022","unstructured":"Dall M, Hassing AS, Treebak JT. NAD+ and NAFLD - caution, causality and careful optimism. J Physiol. 2022;600(5):1135\u201354. https:\/\/doi.org\/10.1113\/JP280908.","journal-title":"J Physiol"},{"key":"328_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.110979","volume":"394","author":"Y Xia","year":"2024","unstructured":"Xia Y, Luo Q, Gao Q, Huang C, Chen P, Zou Y, et al. SIRT1 activation ameliorates rhesus monkey liver fibrosis by inhibiting the TGF-\u03b2\/smad signaling pathway. Chem Biol Interact. 2024;394:110979. https:\/\/doi.org\/10.1016\/j.cbi.2024.110979.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"328_CR42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/j.gastro.2020.03.008","volume":"159","author":"M Mejias","year":"2020","unstructured":"Mejias M, Gallego J, Naranjo-Suarez S, Ramirez M, Pell N, Manzano A, et al. CPEB4 increases expression of PFKFB3 to induce glycolysis and activate mouse and human hepatic stellate cells, promoting liver fibrosis. Gastroenterology. 2020;159(1):273\u201388. https:\/\/doi.org\/10.1053\/j.gastro.2020.03.008.","journal-title":"Gastroenterology"},{"issue":"50","key":"328_CR43","doi-asserted-by":"publisher","first-page":"27953","DOI":"10.1021\/acs.jafc.4c08211","volume":"72","author":"L Li","year":"2024","unstructured":"Li L, Lei Q, Zhen Y, Cao L, Dong Y, Liu X, et al. Lactate dehydrogenase inhibition protects against hepatic fibrosis by regulating metabolic reprogramming of hepatic stellate cells. J Agric Food Chem. 2024;72(50):27953\u201364. https:\/\/doi.org\/10.1021\/acs.jafc.4c08211.","journal-title":"J Agric Food Chem"},{"key":"328_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150732","volume":"734","author":"ZJ Ma","year":"2024","unstructured":"Ma ZJ, Yue SS, Qin BY, Hu YT, Peng AK, Wang QY, et al. Naringenin ameliorates MASH fibrosis via regulating TAK1\/MAPK\/FoxO3a-mediated apoptosis in the activated hepatic stellate cells. Biochem Biophys Res Commun. 2024;734:150732. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150732.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"328_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.14463","volume":"46","author":"J Zhang","year":"2022","unstructured":"Zhang J, Ping J, Jiang N, Xu L. Resveratrol inhibits hepatic stellate cell activation by regulating autophagy and apoptosis through the SIRT1 and JNK signaling pathways. J Food Biochem. 2022;46(12):e14463. https:\/\/doi.org\/10.1111\/jfbc.14463.","journal-title":"J Food Biochem"},{"issue":"5","key":"328_CR46","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/antiox12051075","volume":"12","author":"O Abu Shelbayeh","year":"2023","unstructured":"Abu Shelbayeh O, Arroum T, Morris S, Busch KB. PGC-1\u03b1 is a master regulator of mitochondrial lifecycle and ROS stress response. Antioxidants. 2023;12(5):1075. https:\/\/doi.org\/10.3390\/antiox12051075.","journal-title":"Antioxidants"},{"key":"328_CR47","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/nyas.14872","volume":"1516","author":"H Wang","year":"2022","unstructured":"Wang H, Wang X, Ma L, Huang X, Peng Y, Huang H, et al. PGC-1 alpha regulates mitochondrial biogenesis to ameliorate hypoxia-inhibited cementoblast mineralization. Ann N Y Acad Sci. 2022;1516:300\u201311. https:\/\/doi.org\/10.1111\/nyas.14872.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"328_CR48","doi-asserted-by":"publisher","first-page":"849","DOI":"10.7150\/ijbs.40886","volume":"16","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Yu Z, Hou Y, Zhang L, Fu A. Improvement of cognitive and motor performance with mitotherapy in aged mice. Int J Biol Sci. 2020;16(5):849\u201358. https:\/\/doi.org\/10.7150\/ijbs.40886.","journal-title":"Int J Biol Sci"},{"issue":"17","key":"328_CR49","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1002\/pmic.201100157","volume":"11","author":"W Liu","year":"2011","unstructured":"Liu W, Hou Y, Chen H, Wei H, Lin W, Li J, et al. Sample preparation method for isolation of single-cell types from mouse liver for proteomic studies. Proteomics. 2011;11(17):3556\u201364. https:\/\/doi.org\/10.1002\/pmic.201100157.","journal-title":"Proteomics"},{"issue":"1","key":"328_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s43556-024-00227-6","volume":"5","author":"H Wang","year":"2024","unstructured":"Wang H, Su Z, Qian Y, Shi B, Li H, An W, et al. Pentraxin-3 modulates hepatocyte ferroptosis and the innate immune response in LPS-induced liver injury. Mol Biomed. 2024;5(1):68. https:\/\/doi.org\/10.1186\/s43556-024-00227-6.","journal-title":"Mol Biomed"},{"issue":"1","key":"328_CR51","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1038\/s41598-023-30582-3","volume":"13","author":"L Zhang","year":"2023","unstructured":"Zhang L, Liu C, Yin L, Huang C, Fan S. Mangiferin relieves CCl4-induced liver fibrosis in mice. Sci Rep. 2023;13(1):4172. https:\/\/doi.org\/10.1038\/s41598-023-30582-3.","journal-title":"Sci Rep"},{"issue":"D1","key":"328_CR52","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, et al. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 2025;53(D1):D1670\u20136. https:\/\/doi.org\/10.1093\/nar\/gkae973.","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00328-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00328-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00328-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:31:21Z","timestamp":1760362281000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00328-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["328"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00328-w","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,11]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Animal Care and Use Committee of Southwest University (IACUC-20230925-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have agreed to publish the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}